Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)
ClinicalTrials.gov study NCT07361484. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody
ClinicalTrials.gov study NCT06014944. IPD Sharing: NO. Countries: 0. Publications: 0.
Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer
ClinicalTrials.gov study NCT04046185. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure
ClinicalTrials.gov study NCT07095803. IPD Sharing: NO. Countries: 0. Publications: 0.
Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma
ClinicalTrials.gov study NCT06484153. IPD Sharing: YES. Countries: 0. Publications: 0.
Safety, PK and PD Study in Healthy Male Japanese Subjects
ClinicalTrials.gov study NCT00447941. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe Harmony
ClinicalTrials.gov study NCT06390592. IPD Sharing: NO. Countries: 0. Publications: 0.
SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC
ClinicalTrials.gov study NCT06925048. IPD Sharing: YES. Countries: 0. Publications: 0.
Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects
ClinicalTrials.gov study NCT01036035. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases
ClinicalTrials.gov study NCT06504901. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib
ClinicalTrials.gov study NCT02357732. IPD Sharing: Not stated. Countries: 0. Publications: 0.
PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure
ClinicalTrials.gov study NCT02667535. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies
ClinicalTrials.gov study NCT03999658. IPD Sharing: NO. Countries: 0. Publications: 0.
Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study
ClinicalTrials.gov study NCT05022394. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)
ClinicalTrials.gov study NCT02922530. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With A
ClinicalTrials.gov study NCT05039736. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC
ClinicalTrials.gov study NCT07353476. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT04782089. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy
ClinicalTrials.gov study NCT02142868. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy
ClinicalTrials.gov study NCT06691594. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.